Regeneron Pharmaceuticals Stock Options
| REGN Stock | USD 681.58 11.65 1.68% |
Regeneron Pharmaceuticals' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.53 with a put-to-call open interest ratio of 0.18 over 23 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025. The total put volume is at 4.0, with calls trading at the volume of 6.0. This yields a 0.67 put-to-call volume ratio.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Regeneron Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Regeneron Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Regeneron Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Regeneron Pharmaceuticals
Analyzing Regeneron Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Regeneron Pharmaceuticals regardless of its overall volatility. This is especially true when Regeneron Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Regeneron Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Regeneron Pharmaceuticals' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Regeneron Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Regeneron Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Regeneron Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Regeneron Stock moves the wrong way.
Regeneron Current Options Market Mood
Regeneron Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Regeneron Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Regeneron Pharmaceuticals' options investors are not very successful. Regeneron Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Regeneron contract
Base on the Rule 16, the options market is currently suggesting that Regeneron Pharmaceuticals will have an average daily up or down price movement of about 0.0331% per day over the life of the 2025-03-21 option contract. With Regeneron Pharmaceuticals trading at USD 681.58, that is roughly USD 0.23. If you think that the market is fully incorporating Regeneron Pharmaceuticals' daily price movement you should consider buying Regeneron Pharmaceuticals options at the current volatility level of 0.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Regeneron |
Purchasing Regeneron Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Regeneron calls. Remember, the seller must deliver Regeneron Pharmaceuticals stock to the call owner when a call is exercised.
Regeneron Pharmaceuticals Option Chain
When Regeneron Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Regeneron Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Regeneron Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Regeneron. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Regeneron. It also shows strike prices and maturity days for a Regeneron Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | REGN250321C00700000 | 10 | 700.0 | 30.2 - 38.0 | 35.7 | Out |
Call | REGN250321C00715000 | 1 | 715.0 | 24.0 - 31.7 | 39.1 | Out |
Call | REGN250321C00965000 | 0 | 965.0 | 0.05 - 4.8 | 0.05 | |
Call | REGN250321C00970000 | 0 | 970.0 | 0.05 - 5.0 | 0.05 | |
Call | REGN250321C00975000 | 0 | 975.0 | 0.05 - 4.8 | 0.05 | |
Call | REGN250321C00980000 | 0 | 980.0 | 0.0 - 3.5 | 3.5 | |
Call | REGN250321C00985000 | 0 | 985.0 | 0.05 - 4.8 | 0.05 | |
Call | REGN250321C00990000 | 0 | 990.0 | 0.05 - 4.8 | 0.05 | |
Call | REGN250321C00995000 | 0 | 995.0 | 0.05 - 4.8 | 0.05 | |
Call | REGN250321C01000000 | 0 | 1000.0 | 0.0 - 4.7 | 4.7 | |
Call | REGN250321C01020000 | 0 | 1020.0 | 0.0 - 4.6 | 0.45 | |
Call | REGN250321C01040000 | 0 | 1040.0 | 0.0 - 4.6 | 0.5 | |
Put | REGN250321P00700000 | 2 | 700.0 | 44.0 - 50.3 | 45.2 | In |
Put | REGN250321P00965000 | 0 | 965.0 | 278.8 - 286.6 | 278.8 | In |
Put | REGN250321P00970000 | 0 | 970.0 | 283.8 - 292.0 | 283.8 | In |
Put | REGN250321P00975000 | 0 | 975.0 | 288.8 - 297.0 | 288.8 | In |
Put | REGN250321P00980000 | 0 | 980.0 | 293.8 - 302.1 | 293.8 | In |
Put | REGN250321P00985000 | 0 | 985.0 | 298.1 - 308.0 | 298.1 | In |
Put | REGN250321P00990000 | 0 | 990.0 | 303.9 - 312.0 | 303.9 | In |
Put | REGN250321P00995000 | 0 | 995.0 | 308.8 - 317.0 | 308.8 | In |
Put | REGN250321P01000000 | 0 | 1000.0 | 313.8 - 322.1 | 313.8 | In |
Put | REGN250321P01020000 | 0 | 1020.0 | 333.8 - 342.0 | 333.8 | In |
Put | REGN250321P01040000 | 0 | 1040.0 | 353.8 - 362.0 | 353.8 | In |
Regeneron Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Regeneron Total Stockholder Equity
Total Stockholder Equity |
|
Regeneron Pharmaceuticals Corporate Management
| Joseph JD | General VP | Profile | |
| Patrice Gilooly | Senior Operations | Profile | |
| Andrew Murphy | Executive Research | Profile | |
| Christopher CPA | Head Finance | Profile | |
| Bob McCowan | Senior Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.298 | Earnings Share 40.42 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.